Last reviewed: May 25, 2026 Last updated: May 25, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
At our practice, we frequently combine both approaches
Magtanong, D
Cardiovascular research shows BPC-157 protects against drug-induced cardiac damage and improves healing after myocardial infarction in animal models
Such a strategy could include thyroid function assessment at GLP-1RA initiation, and every 3 months during active weight loss period (or more frequent, e.g., every month when 5% weight reduction is achieved), and timely levothyroxine dose titration to optimize thyroid hormone replacement
Hypoxic-Ischemic-Related cerebrovascular changes and potential therapeutic strategies in the neonatal brain